Providing solutions for product development, clinical research, and contract manufacturing in the pharmaceutical and biopharmaceutical industries.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: May 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
3P Biopharmaceuticals
B
Providing biopharmaceutical manufacturing services including process development, analytical testing, clinical production, and large-scale commercial manufacturing.
NextPharma
A
Pharmaceutical development and manufacturing, including drug development, clinical trials services, commercial manufacturing and packaging, and health and nutrition solutions.
Cerba Research
A
Providing specialized laboratory services and biotechnology solutions for clinical research, pharmaceutical industry, and public health organizations.
Initiatives identified among leaders
Réduction des émissions CO₂ alignée sur l'Accord de Paris via SBTi.
“Cerba HealthCare s'est engagé à réduire ses émissi...” - Cerba ResearchFormations et intégration des employés pour renforcer compétences et diversité
“NextPharma met en place des programmes pour amélio...” - NextPharmaDéfinition d'une stratégie RSE structurée autour de quatre piliers
“En 2022, Cerba Research a défini une stratégie RSE...” - Cerba Research54% of similar organizations communicate on CSR issues
+656 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports